Immunogenicity and tolerability of hepatitis A vaccine in HIV-infected children.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 16028166.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The immunogenicity and tolerability of hepatitis A virus vaccine was evaluated in a group of 32 children with human immunodeficiency virus (HIV) infection and 27 children with seroreversion. After 2 doses of vaccine, 100% of children experienced seroconversion with good toleration of the vaccine. There were no differences in variation of virus load between immunized HIV-positive children and a group of 31 nonimmunized HIV-positive children with similar characteristics.
Medical subject headings
- HIV Infections
- Hepatitis A Antibodies
- Hepatitis A Vaccines
- Immune Tolerance